化學制劑是一本同行評議的普通化學雜志，它為讀者帶來了以化學為中心的多學科研究的最佳成果。化學制劑在其范圍內(nèi)全面發(fā)表文章，涵蓋化學或化學的兩個不同方面（子領域）或另一個科學學科（一個化學主題加上另一個，因此標題為化學制劑）的新成果。所有合適的提交文件都經(jīng)過該領域專家的平衡同行評審，以確保最高的質量、原創(chuàng)性、相關性、重要性和有效性化學制劑提供…短出版時間，以接受文章（已提交；應作者要求）和早期查看（記錄的排版版本）狀態(tài)持續(xù)出版，更快地提供最終和可引用的文章免費復制彩色圖形綜合了全文、通信、評論和小評論包括簡介、特殊問題和虛擬問題通過編輯經(jīng)理提交和管理稿件在所有提交文件中應用iFective軟件以確保真實性和獨創(chuàng)性。威利VCH期刊編輯部之間密切合作，確保高質量的研究能找到最合適的論壇。通過聯(lián)機開放程序打開訪問發(fā)布適用于iPhone/iPad和Android的免費應用程序通過社交媒體推廣內(nèi)容：Twitter、Facebook《化學觀點》和《高等科學新聞》選文的突出通過早期職業(yè)系列和相關訪談支持未來的主要研究人員

ChemPlusChem is a peer-reviewed, general chemistry journal that brings readers the very best in multidisciplinary research centering on chemistry. Fully comprehensive in its scope, ChemPlusChem publishes articles covering new results from at least two different aspects (subfields) of chemistry or one of chemistry and one of another scientific discipline (one chemistry topic plus another one, hence the title ChemPlusChem). All suitable submissions undergo balanced peer review by experts in the field to ensure the highest quality, originality, relevance, significance, and validity.ChemPlusChem offers...short publication times to Accepted Article (as-submitted; at authors' request) and EarlyView (typeset version of record) statuscontinuous publishing making final and citable articles available fasterfree reproduction of color graphicsa mix of Full Papers, Communications, Reviews and Minireviewscover profiles, special issues and virtual issuesmanuscript submission and management through Editorial Managerthe application of iThenticate software to all submissions to ensure authenticity and originalityclose cooperation between the editorial offices of Wiley-VCH journals to ensure that high-quality research will find the most appropriate forumopen access publishing through the OnlineOpen programa free app for iPhone/iPad and Androidpromotion of content through social media: Twitter, Facebookhighlighting of selected articles in ChemistryViews and Advanced Science Newssupport for leading researchers of the future through the Early Career Series and associated Interviews